INTRODUCTION
============

A high level of adherence to antiretroviral therapy (ART) is necessary to maintain viral suppression and achieve optimal clinical outcomes for HIV-infected persons \[[@R1],[@R2]\], though there is little consensus on the minimum threshold of adherence needed for virologic suppression \[[@R3],[@R4]\]. Medication adherence often accompanies other healthy behaviors such as diet and health care utilization \[[@R5]\]. ART may also improve population health, reduce the number of premature deaths, and lower health care costs, as studies indicate that access and adherence to ART may play an important role in reducing HIV transmission by suppressing HIV viral load (VL) \[[@R6],[@R7]\]. Successful ART requires clinicians to assess the risks of nonadherence before deciding on a regimen and to accurately monitor and support adherence throughout therapy \[[@R8],[@R9]\].

Clinical outcomes have been better predicted by measuring multiple dimensions of medication-taking behaviors than by measuring missed doses \[[@R10]\]. Gill and colleagues found the timing of doses to be important for VL suppression \[[@R11]\]. Despite these findings, many studies of ART adherence have been focused on missed doses, not on adherence to medication schedules and special instructions such as dietary restrictions. Failure to inquire about adherence to schedule and instruction may lead to inaccurate estimates of a patient's level of adherence and may thus result in missed opportunities to educate or failure to identify nonadherence as a cause of treatment failure. The few studies that have compared different dimensions of nonadherence have found that their predictors vary \[[@R12],[@R13]\]. Because multiple measures of nonadherence have proved useful in predicting clinical outcomes and our knowledge of their predictors (and how they may vary across measures) is limited, examination of multiple measures is warranted. Better knowledge of these factors may inform the development of interventions to improve all aspects of adherence.

The primary objective of our analysis was to describe the use of ART and to assess the various measures of ART nonadherence in a national sample of adult HIV patients. A secondary objective was to explore the factors associated with the various dimensions of medication-taking behavior, which have been incompletely described to date.

METHODS
=======

We performed a cross-sectional analysis of data from the Medical Monitoring Project (MMP), a supplemental surveillance system for collecting clinical and behavioral data on HIV-infected adults receiving care. The methods have been described in detail elsewhere \[[@R14],[@R15]\]. MMP uses a three-stage sampling design to obtain annual cross-sectional probability samples of HIV-infected adults in care. In the first stage, states are selected to participate, then HIV care facilities in these states are sampled, and finally HIV-infected adults in care at participating facilities are sampled. Face-to-face interviews are conducted to collect information on demographics, adherence to HIV medication regimens, and behavioral risk factors. The data were collected in 19 states and Puerto Rico from June 2007 through September 2008.^[1](#FN1){ref-type="fn"}^ The Centers for Disease Control and Prevention has determined that MMP is not human subjects research because it is a routine disease surveillance activity. However, participating project areas obtain local Institutional Review Board (IRB) approval to conduct MMP as required locally. We asked participants about their medication-taking behaviors during the 48 hours before interview. *Dose nonadherence* refers to failure to take a prescribed dose or set of pills/spoonfuls/injections of antiretroviral (ARV) medications. *Schedule nonadherence* refers to failure to follow the prescribed schedule for ARV medications, such as "2 times a day" or "every 8 hours." *Instruction nonadherence* refers to failure to follow special instructions accompanying ARV medication prescriptions, such as "take with food" or "take on an empty stomach." Instruction nonadherence was asked of only the participants who reported having received special instructions for their ARV medications. Although self-reported measures have generally been found to indicate lower nonadherence than other measures (such as pill counts, Medication Event Monitoring System \[MEMS\] devices, or pharmacy refill records), no standard exists for measuring nonadherence \[[@R16]\] and self-reported measures have been correlated with clinical outcomes such as VL \[[@R17]\]. We defined nonadherence as failure to take ARV medication exactly as prescribed (i.e., 100% of doses taken for dose adherence, 100% of doses on the prescribed schedule for schedule adherence, and 100% instructions followed for instruction adherence) given that 100% adherence is a common threshold for self-reported measures \[[@R18]\].

After determining the frequencies of selected characteristics to describe participants currently taking ART and those not taking ART, we tested for differences in these characteristics by using chi-square tests. To assess whether our measures of nonadherence are related to clinical outcomes, we then tested for bivariate associations between each of the three measures of nonadherence and self-reported undetectable VL, using the Mantel-Haenszel chi-square test and binomial logistic regression. In addition, we used these methods to examine the relationship between the total number of reported nonadherence measures (measured as 0 = 100% adherent on all three measures, 1 = nonadherent on one measure, 2 = nonadherent on two measures, 3 = nonadherent on all three measures) and self-reported undetectable VL.

Finally, to explore differences in the factors associated with the measures of nonadherence, we tested for bivariate relationships between dose, schedule, and instruction nonadherence and the factors associated with nonadherence in the scientific literature. Factors associated with each measure of nonadherence (significant at the p \< 0.10 level) were included in three multivariate regression models. Final models were determined by using backward stepwise regression with a p \< 0.05 retention criterion. Model fit was assessed by using the Hosmer and Lemeshow goodness-of-fit test.

All independent variables refer to the past 12 months except where otherwise noted. The following independent variables were examined for each of the three models:Sociodemographic: gender, age at interview, race/ethnicity, educational attainment (\<high school, \>high school or equivalent), receipt of public assistance, homelessness (defined as living on the street, in a shelter, a single-room-occupancy hotel, temporarily staying with friends/family, or living in a car), lack of continuous health insurance coverageAlcohol and drug use: crack use, amphetamine use, binge drinking in the past 30 days (\>4 drinks per day for men, \>3 drinks per day for women)Mental health: feeling downhearted and depressed in past 4 weeks (5-point Likert scale ranging from 1 = "none of the time" to 5 = "all of the time")HIV-related: not knowing most recent VL test result, number of daily ARV doses (defined as a set of pills/spoonfuls/injections of antiretroviral (ARV) medications), years since HIV diagnosis, having a discussion with a provider about ARV drug resistance

RESULTS
=======

All sampled states and territories agreed to participate in MMP. During January-April 2007, a sample of 10,503 patients was selected from 582 participating HIV care facilities in the 26 participating project areas. The overall median facility participation rate was 91.4% (range across project areas, 65% to 100%). Of the sample, 311 were ineligible, resulting in a total of 10,192 patients. Reasons for ineligibility included: 29 duplicates, 18 less than 18 years of age, 63 HIV-negative, 114 no care during the sample selection period, and 87 ineligible for other reasons. The median patient participation rate was 40% (range across project areas, 3% to 76%). A total of 3,944 standard interviews were conducted from June 2007 through September 2008. For this analysis, the data of 43 participants were excluded because interviewers were not confident of the validity of the responses (for example, cases where the participant was incoherent or unresponsive to interview questions).

Antiretroviral Therapy Use
--------------------------

Of 3886 participants who provided information about ART, 3307 (85%) were currently taking ART. Roughly equal proportions had never taken ART (8%) or had previously taken ART (7%). Compared to those not currently taking ART, those who were currently taking ART were significantly more likely to be male, older, non-Hispanic white (hereafter referred to as white) or Hispanic, HIV-diagnosed for a longer period of time, and not homeless; to have continuous healthcare coverage for the past year and a lower self-reported nadir CD4+ T-lymphocyte (CD4) count; to report a lower VL and feeling downhearted and depressed (hereafter referred to as depressed) less often; to know the result of their most recent VL test; and not to receive public assistance, not to use crack or amphetamines, and not to binge drink (Table **[1](#T1){ref-type="table"}**).

Nonadherence to Antiretroviral Therapy
--------------------------------------

Table **[2](#T2){ref-type="table"}** presents descriptive statistics for participants who reported nonadherence during the past 48 hours. Of MMP participants currently taking ART, 13% reported nonadherence to dose, 27% to schedule, and 30% to instruction. Considering all measures, nonadherence was reported by 38% of participants: 22% reported nonadherence to one measure, 11% to two measures, and 5% to all three measures.

Association between Self-reported Detectable Viral Load and Nonadherence
------------------------------------------------------------------------

Participants were asked about the results of their most recent VL test (see Table **[2](#T2){ref-type="table"}**). Tests of association revealed statistically significant positive relationships between nonadherence and detectable VL test result (p \< 0.0001 for dose and schedule nonadherence and p = 0.03 for instruction nonadherence). In addition, there was a significant and positive association between the number of nonadherence measures reported and detectable VL (p \< 0.0001). Logistic regression modeling results indicated that the odds of a detectable VL more than doubled for those reporting dose nonadherence (odds ratio \[OR\], 2.2; 95% confidence interval \[CI\], 1.7-2.8). Similar analyses yielded an OR of 2.1 for schedule nonadherence (CI, 1.7-2.6) and 1.3 for instruction nonadherence (CI, 1.0-1.7). In addition, nonadherence to multiple measures was associated with increased odds of a detectable VL. In a comparison of participants who reported nonadherence and participants who did not, the odds of detectable VL was 1.3 times as high (CI, 1.0-1.7) for those who reported nonadherence to one measure, 2.1 times as high (CI, 1.6-2.8) for those who reported nonadherence to two measures, and 2.9 times as high (CI, 2.0-4.1) for those who reported nonadherence to all three measures.

Factors Associated with Each Measure of Nonadherence
----------------------------------------------------

The factors independently associated with dose nonadherence were female gender; per year decrease in age; non-Hispanic black (hereafter referred to as black) and

Hispanic race/ethnicity; receipt of public assistance; feeling depressed all, most, or some of the time; crack use; binge drinking; higher number of years since HIV diagnosis; and higher number of daily ARV doses (Table **[3](#T3){ref-type="table"}**). The factors independently associated with schedule nonadherence were female gender, per year decrease in age, black and Hispanic race/ethnicity, less than high school education, homelessness, receipt of public assistance, binge drinking, higher number of daily ARV doses, and not knowing one's most recent VL test result. The factors independently associated with instruction nonadherence were per year decrease in age; feeling depressed most, some, or a little of the time; and binge drinking.

DISCUSSION
==========

Although studies on nonadherence to ART are common, one strength of this analysis is the use of probability sampling methods, which resulted in coverage of patients from 582 medical facilities in 19 U.S. states and Puerto Rico. The use of ART was high among adults in care for HIV. The persons not receiving ART were more likely to be female, to be black, and to report a lapse in health coverage, substance use, higher VL results, higher CD4 count as the nadir, and more frequent feelings of depression. Our findings agree with those in other reports \[[@R19]-[@R25]\]. Understanding factors associated with use of ART may inform efforts to increase appropriate ART among HIV-infected persons.

Nonadherence to ART was substantial. Reported nonadherence during the past 48 hours ranged from 13% to 30%, depending on which measure was examined; 38% were nonadherent to at least one measure. We found a direct relationship between a detectable VL and each of the three measures of nonadherence. The association increased with the number of measures to which a patient was nonadherent, indicating the clinical importance of assessing multiple dimensions of nonadherence. Our findings are consistent with those reported previously \[[@R10],[@R11]\], but there have been few studies comparing dose, schedule, and instruction nonadherence, so further examination of the impact of different measures of nonadherence on clinical outcomes is warranted.

Although predictors of the three measures of nonadherence varied, younger age and binge drinking were consistently associated with poorer adherence. Like other researchers \[[@R26]\], we found associations between younger age and multiple measures of nonadherence. Lifestyle differences, decreased awareness of mortality and thus motivation to care for one's health, and a survivor effect have been proposed as reasons for poorer adherence among younger HIV-infected persons \[[@R27]\]. Measured in various ways, alcohol use has consistently been associated with nonadherence \[[@R28],[@R29]\]. We found that binge drinking was strongly associated with all three measures of nonadherence. Others have found that the quantity of alcohol ingested was more important in predicting nonadherence than was the frequency of use \[[@R29],[@R30]\]. Taken together, these findings suggest that HIV care providers should ask patients about both the frequency and the quantity of alcohol consumed. When a patient acknowledges binge drinking, the provider should explain how binge drinking affects ART adherence and other health behaviors. Such conversations could help HIV care providers identify patients who need more intensive counseling about adherence and substance use. Few effective interventions have addressed problem drinking among HIV-infected persons \[[@R31]\], and the effects of the small number of trials on adherence among problem drinkers have not been sustained \[[@R32],[@R33]\]. The limited evidence suggests that adapting adherence interventions to persons with alcohol problems may be challenging \[[@R31]\]. Our results underscore the need to develop effective adherence interventions for problem drinkers, which potentially could have positive effects on all aspects of adherence.

Black and Hispanic race/ethnicity, female gender, receipt of public assistance, feeling depressed, and number of daily ARV doses were also independently associated with poorer adherence for at least two of the three measures of nonadherence. Several recent studies have found that race/ethnicity is independently associated with nonadherence \[[@R17],[@R34],[@R35]\]. Race/ethnicity may also be a proxy for factors associated with nonadherence, such as differences in trust of physicians \[[@R36]\] or HIV conspiracy beliefs (e.g., the belief that HIV was created by the U.S. government to perpetrate genocide against blacks) \[[@R37]\]. Recent studies indicate that disparities in health literacy and numeracy skills, which we were not able to measure, may also be important mediators of the relationship between race and medication management \[[@R38],[@R39]\].

Similar to findings regarding adherence to treatment for chronic diseases such as diabetes \[[@R40]\], published descriptions of the effect of gender on ART adherence in the scientific literature have been mixed; some studies find women more likely to be nonadherent \[[@R41],[@R42]\], and others find no difference by gender \[[@R43]\]. Our finding suggests gender may influence some, but not all, dimensions of medication-taking behavior (dose and schedule nonadherence, but not instruction nonadherence). Another possible explanation for the observed gender differences is that other factors affecting nonadherence, such as alcohol or drug use, may differ for men and women \[[@R44]\]. Additional factors we were not able to measure, such as numeracy skills \[[@R45]\], may also mediate the relationship between gender and nonadherence.

Our finding that the frequency of feelings of depression was associated with dose and instruction nonadherence to ART is consistent with other studies \[[@R46],[@R47]\]. This association reinforces the importance of active screening for depression among HIV-infected persons \[[@R48]\]. Studies have suggested that training in stress management \[[@R49]\] and prescription of antidepressant medications \[[@R50]\] may improve adherence in this population.

Our finding that nonadherence increases as the daily ARV dose increases agrees with published results \[[@R51],[@R52]\]. Airoldi and colleagues found that switching to a single-pill regimen improved adherence \[[@R53]\]. Although some ART regimens are less susceptible to nonadherence than others \[[@R9]\], our findings suggest that simplifying ART regimens by decreasing dosing frequency would improve adherence.

LIMITATIONS
===========

Although MMP uses population-based sampling methods, due to low patient response rates across data collection sites MMP data are not weighted and thus are not representative of HIV-infected patients in care in the United States. However, probability sampling is advantageous even with low response rates because of the value of unbiased sampling from well-defined populations \[[@R54]\]. States with the lowest patient response rates were not substantially different by region or HIV epidemiology from those with higher response rates. Examination of the patient sampling frame indicates that respondents and nonrespondents did not differ by gender. Participants were slightly older than nonparticipants, and African Americans were somewhat underrepresented. Because we found that younger age and black race are associated with higher nonadherence, as have other studies \[[@R17],[@R26],[@R34],[@R35]\], these relationships may in fact be stronger than those found for our sample. Despite low patient response, the response rates at the project area and facility stages of sampling were high, and the size and breadth of our facility and patient samples are notable.

Because we studied self-reported measures, our findings are subject to the limitations of self-reported information, such as recall and social desirability biases. Because self-reported measures of adherence have underestimated the extent of nonadherence \[[@R16],[@R18]\], our estimates of nonadherence may in fact be lower than actual levels of nonadherence. In addition, we were not able to verify through medical record review self-reported clinical information such as receipt of ART. However, Wood and colleagues found relatively high correspondence between self-reported and medical record documentation of current use of ART \[[@R55]\], leading us to have confidence in our results. Also, our analysis was restricted to self-reported VL, and the number of missing responses was high because of difficulties with recall. However, for undetectable VL results, the reported agreement between self-report and the medical record has been relatively high \[[@R56],[@R57]\]. Also, as our data showed a positive association between dose and schedule nonadherence and not knowing one's most recent VL, it is unlikely that missing data would account for the relationship found between higher VL and the number of nonadherence measures reported.

Our analysis of use of ART is limited due to lack of comprehensive clinical information that would allow us to determine need for therapy among those not on ART. Use of self-reported CD4 values to indicate need for ART is insufficient because other clinical factors are also relevant to treatment decisions (e.g. Hepatitis B coinfection, HIV-associated nephropathy). In addition, because recent treatment guidelines \[[@R8]\] suggest that ART should be an option for all patients regardless of CD4, we felt it was important to describe the difference between those on and not on ART for the entire sample.

Our logistic regression models regarding nonadherence to instruction included only the participants who had received special instructions. However, limiting our analysis of the dose and schedule nonadherence models to those who received special instructions would have introduced bias by restricting the population to those whose regimens require special instructions. To ensure that our findings were not due to differences in the participants included in the models, we ran the dose and schedule models, restricting them to participants who have received special instructions: we did not find substantive differences compared with results that included all respondents.

CONCLUSION
==========

Recent guidelines recommend initiation early in the course of infection (CD4 cell count ≤500 cells/µL), but caution that patients should be willing to commit to lifelong treatment and should understand the importance of adherence \[[@R8]\]. In this large sample of HIV-infected patients in the United States, the use of ART was high, but adherence to ART was suboptimal. The determinants of nonadherence to dose, schedule, and instruction varied, although younger age and binge drinking were associated with all three measures. Our results support the need to measure multiple dimensions of medication-taking behavior, because focusing on nonadherence to dose may overestimate adherence to ART. Comprehensive assessment of ART nonadherence should include measures of dose, schedule, and instruction, because accurate information is crucial for evaluating both the effectiveness of ART regimens and interventions designed to increase adherence.
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###### 

Factors associated with current use of ART--United States, Medical Monitoring Project, 2007-2008

  -------------------------------------------------------------------------------------------------------------------------------------------------
                                                     Currently\              Not Currently Taking ART (n = 579)   Chi-Square Test for Differences
                                                     Taking ART (n = 3307)                                        
  -------------------------------------------------- ----------------------- ------------------------------------ ---------------------------------
  Gender\                                            \                       \                                    \
  Male                                                  2431      74            373      64                       20.52

  Female                                                830       25            197      34                       (\<.0001)

  Transgender                                           45        1              8       1                        

                                                                                                                  

  Age (years)\                                       \                       \                                    \
  18-24                                                 45        1             33       6                        118.82

  25-34                                                 280        8            101      17                       (\<.0001)

  35-44                                                 1039       31           214      37                       

  45-54                                                 1311       40           180      31                       

  ≤55                                                   632       19            51       9                        

                                                                                                                  

  Race/ethnicity\                                    \                       \                                    \
  Black, non-Hispanic                                   1254      38            288      50                       31.26

  Hispanic                                              663       20            95      16                        (\<.0001)

  White, non-Hispanic                                   1173      35            156      27                       

  Other                                                 212       6             39       7                        

                                                                                                                  

  Education\                                         \                       \                                    \
  \< High School                                         729      22            149      26                       3.81

  ≥ High School or equivalent                           2576      78            430      74                       (0.05)

                                                                                                                  

  Public assistance, past 12 months\                 \                       \                                    \
  No                                                    1639      50            322      56                       7.4

  Yes                                                   1667      50            256      44                       (0.01)

                                                                                                                  

  Lapse in health coverage, past 12 months\          \                       \                                    \
  No                                                    2491      75            379      65                       24.06

  Yes                                                   808       24            197      34                       (\<.0001)

                                                                                                                  

  Homeless, past 12 months\                          \                       \                                    \
  No                                                    3080      93            500      86                       31.22

  Yes                                                   227       7             79      14                        (\<.0001)

                                                                                                                  

  Years since HIV diagnosis\                         \                       \                                    \
  ≤ 1                                                   18        1             5       1                         57.43

  2-5                                                   616       19            189      33                       (\<.0001)

  6-10                                                  764       23            127      22                       

  11-25                                                 1711      52            226      39                       

                                                                                                                  

  Knew most recent HIV viral load test result\       \                       \                                    \
  No                                                    639       19            162      28                       27.41

  Yes                                                   2587      78            383      66                       (\<.0001)

                                                                                                                  

  Most recent HIV viral load test result\            \                       \                                    \
  Undetectable                                          2056      62            110      19                       482.24

  Detectable but \<5000                                 307       9             93      16                        (\<.0001)

  ≥5000-\<100000                                        166       5             142      25                       

  ≥100000                                                58        2            38       7                        

  Missing                                                720      22               196      34                    

                                                                                                                  

  CD4 count (self-reported nadir)\                   \                       \                                    \
  0-199                                                 1511      46            90      16                        218.3

  200-349                                               642       19              128      22                     (\<.0001)

  350-499                                               261       8               112      19                     

  500+                                                  140       4               102      18                     

  Missing                                               753       23              147      25                     

                                                                                                                  

  Feeling downhearted and depressed, past 4 weeks\   \                       \                                    \
  All of the time                                       140       4             39      7                         10.91

  Most of the time                                      315      10                77      13                     (0.00)

  Some of the time                                      992      30               155      27                     

  A little of the time                                  799      24               153      26                     

  None of the time                                      1054     32               154      27                     

                                                                                                                  

  Crack use, past 12 months\                         \                       \                                    \
  No                                                    3128     95             521      90                       19.45

  Yes                                                   167      5                 56      10                     (\<.0001)

                                                                                                                  

  Amphetamine use, past 12 months\                   \                       \                                    \
  No                                                    3142     95             537      93                       5.6

  Yes                                                   152      5                 40       7                     (0.02)

                                                                                                                  

  Binge drinking, past 30 days\                      \                       \                                    \
  No                                                    2864      87            459      79                       21.19

  Yes                                                    426     13                116      20                    (\<.0001)
  -------------------------------------------------------------------------------------------------------------------------------------------------

Note: ART, antiretroviral therapy; values may not sum to total due to missing data; missing values shown when \>10% of total.

###### 

Nonadherence to ART During the Past 48 Hours--United States, Medical Monitoring Project, 2007-2008

                                                         Currently Taking ART   Dose[a](#T2F2){ref-type="table-fn"}   Schedule[b](#T2F3){ref-type="table-fn"}   Instruction[c](#T2F4){ref-type="table-fn"}
  ------------------------------------------------------ ---------------------- ------------------------------------- ----------------------------------------- --------------------------------------------
   Gender                                                                                                                                                       
      Male                                                2431     74            293     66    15.6                    2591    66    34.68                       462    72    1.60
     Female                                               830     25             145     33    (0.00)                  289   32   (\<.0001)                      167   26   (0.45)
      Transgender                                         45      1              6       1                             13    1                                   9    1
                                                                                                                                                                
   Age (years)                                                                                                                                                  
      18-24                                               45      1              18      4     11.33                   21    2    12.48                          17    3    25.85
      25-34                                               280      8             43      10    (0.00)                  83    9    (0.00)                         68    11    (\<.0001)
      35-44                                               1039     31            135     30                            300    34                                 226    35
      45-54                                               1311     40            182     41                            340    38                                 245    38
      ≤55                                                 632     19             66     15                             149    17                                 82    13
                                                                                                                                                                
   Race/ethnicity                                                                                                                                               
      Black, non-Hispanic                                 1254     38            208    47    33.14                    400    45    64.78                        243    38    0.86
      Hispanic                                            663     20             102    23    (\<.0001)                219    25    (\<.0001)                    146    23    (0.83)
      White, non-Hispanic                                 1173    36             105    24                             230    26                                 207    32
      Other                                               212     6              29     7                              44    5                                   42    7
                                                                                                                                                                
   Education                                                                                                                                                    
      \< High School                                      729     22             111    25    2.68                     250    28    25.41                        149    23    0.88
      ≥ High School or equivalent                         2576     78            332    75    (0.10)                   643    72    (\<.0001)                    488    77    (0.35)
                                                                                                                                                                
   Public assistance, past 12 months                                                                                                                            
      No                                                  1639    50             184    41    13.58                    380    43    23.85                        323    51    0.03
      Yes                                                 1667    50             260    59    (0.00)                   513    57    (\<.0001)                    315    49    (0.86)
                                                                                                                                                                
   Lapse in health coverage, past 12 months                                                                                                                     
      No                                                  2491    76             327    74    0.64                     671    75    0.04                         453    71    0.94
      Yes                                                 808     24             115    26    (0.42)                   220    25    (0.84)                       185    29    (0.33)
                                                                                                                                                                
   Homeless, past 12 months                                                                                                                                     
      No                                                  3080    93             398    90    9.81                     808    90    13.63                        581    91    3.47
      Yes                                                 227     7              46    10    (0.00)                    85    10    (0.00)                        57    9    (0.06)
                                                                                                                                                                
   Years since HIV diagnosis                                                                                                                                    
      ≤ 1                                                 18      1              \<5     \<1    6.29                   \<5     \<1    4.00                       \<5     1    1.03
      2-5                                                 616     20             69    17    (0.01)                    140    17    (0.05)                       131    22    (0.31)
      6-10                                                764     25             93    22                              219    26                                 147    25
      11-25                                               1711     55            254    61                             467    56                                 315    53
                                                                                                                                                                
   Knew most recent HIV viral load test result                                                                                                                  
      No                                                  639     20             108    25    8.14                     238    27    44.22                        104    17    2.25
      Yes                                                 2587     80            326    75    (0.00)                   629    73    (\<.0001)                    513    83    (0.13)
                                                                                                                                                                
   Most recent HIV viral load test result                                                                                                                       
      Undetectable                                        2056    62             218    49    44.11                    438    49    49.47                        384    60    4.48
      Detectable but \<5000                               307     9              54    12    (\<.0001)                 104    12    (\<.0001)                    73    11    (0.03)
       ≥5000-\<100000                                     166     5              36    8                               61    7                                   41    6
       ≥100000                                            58      2              18    4                               26    3                                   15    2
      Missing                                             720     22             118    27                             264    30                                 125    20
                                                                                                                                                                
    Feeling downhearted and depressed, past 4 weeks                                                                                                             
      All of the time                                     140     4              36    8    29.39                      39    4    12.11                          32    5    14.15
      Most of the time                                    315    10              56    13    (\<.0001)                 104    12    (0.00)                       67    11    (0.00)
      Some of the time                                    992    30              143    32                             287    32                                 212    33
      A little of the time                                799    24              97    22                              215    24                                 165    26
       None of the time                                    1054   32              110     25                            245     28                                158     25
                                                                                                                                                                
   Crack use, past 12 months                                                                                                                                    
      No                                                  3128    95             403    91    18.36                    829    93    8.00                         597    94    4.69
      Yes                                                 167    5               41    9    (\<.0001)                  61    7    (0.00)                         39    6    (0.03)
                                                                                                                                                                
    Amphetamine use, past 12 months                                                                                                                             
      No                                                  3142    95             418    94    1.72                     842    95    0.74                         601    95    3.30
     Yes                                                   152    5               26     6     (0.19)                   46     5     (0.39)                       34     5     (0.07)
                                                                                                                                                                
   Binge drinking, past 30 days                                                                                                                                 
      No                                                  2864    87             359    81    16.42                    745    84    11.41                        519    82    29.95
      Yes                                                 426     13             84    19    (\<.0001)                 144    16    (0.00)                       115    18    (\<.0001)
                                                                                                                                                                
    Discussed resistance with provider, past 12 months                                                                                                          
      No                                                  1174    36             128    29    10.12                    310    35    0.24                         197    31    0.33
      Yes                                                  2079    64             309     71     (0.00)                 567     65     (0.62)                     431     69     (0.56)

Note: ART, antiretroviral therapy; OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval; Ref, reference category; NS, not significant.

*Dose nonadherence* refers to not taking a dose or set of pills/spoonfuls/injections of ARV medications.

*Schedule nonadherence* refers to not following a specific schedule for ARV medication, such as "2 times a day" or "every 8 hours."

*Instruction nonadherence* refers to not following special instructions for ARV medication, such as "take with food" or "take on an empty stomach." Dietary instruction adherence is only calculated for those participants reporting having special instructions for their ARV medications.

###### 

Logistic Regression Models of Factors Associated with Nonadherence to ART During the Past 48 Hours--United States, Medical Monitoring Project, 2007-2008

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                       Dose[a](#T3F2){ref-type="table-fn"} Nonadherence\   Schedule[b](#T3F3){ref-type="table-fn"} Nonadherence\   Instruction[c](#T3F4){ref-type="table-fn"} Nonadherence\
                                                       (N = 3307)                                          (N = 3298)                                              (N = 2101)
  ---------------------------------------------------- --------------------------------------------------- ------------------------------------------------------- ----------------------------------------------------------
  Characteristic                                       OR\                                                 OR (95% CI) aOR (95% CI)                                OR (95% CI) aOR (95% CI)
                                                       (95% CI) aOR (95% CI)                                                                                       

                                                                                                                                                                   

  Gender                                                                                                                                                             NS

   Male                                                Ref           Ref                                   Ref           Ref                                       

   Female                                              1.55 (1.24-1.92)   1.36 (1.07-1.74)                 1.66 (1.40-1.97)   1.46 (1.20-1.76)                     

   Transgender                                         1.12 (0.47-2.68)   0.62 (0.21-1.80)                 1.26 (0.66-2.42)   0.99 (0.49-2.01)                     

                                                                                                                                                                   

  Age (years)                                          0.98 (0.97-0.99)   0.98 (0.96-0.99)                 0.99 (0.98-0.99)   0.98 (0.98-0.99)                     0.97 (0.96-0.98)   0.98 (0.97-0.99)

                                                                                                                                                                   

  Race/ethnicity                                                                                                                                                     NS

   Black, non-Hispanic                                 2.02 (1.58-2.60)  1.96 (1.48-2.59)                  1.93 (1.60-2.32)  1.56 (1.27-1.93)                      

   Hispanic                                            1.85 (1.38-2.47)   1.63 (1.18-2.24)                 2.03 (1.63-2.52)   1.59 (1.25-2.02)                     

   White, non-Hispanic                                 Ref          Ref                                    Ref           Ref                                       

   Other                                               1.61 (1.04-2.50)   1.55 (0.96-2.51)                 1.07 (0.75-1.54)  0.97 (0.66-1.41)                      

                                                                                                                                                                   

  Education                                              NS                                                                                                          NS

   \< high school                                      Ref           Ref                                                                                           

   ≥ high school or equivalent                         0.64 (0.53-0.76)   0.78 (0.64-0.95)                                                                         

                                                                                                                                                                   

  Homeless, past 12 months                                                                                                                                         

   No                                                  Ref           Ref                                   Ref           Ref                                       Ref           Ref

   Yes                                                 1.71 (1.22-2.41)   -                                1.69 (1.28-2.24)   1.43 (1.05-1.95)                     1.38 (0.98-1.94)   -

                                                                                                                                                                   

  Public assistance, past 12 months                                                                                                                                  NS

   No                                                  Ref           Ref                                   Ref           Ref                                       

   Yes                                                 1.46 (1.19-1.79)   1.31 (1.05-1.65)                 1.47 (1.26-1.72)   1.35 (1.14-1.60)                     

                                                                                                                                                                   

  Feeling downhearted and depressed, past 4 weeks                                                                                                                  

   All of the time                                     2.97 (1.94-4.56)   2.63 (1.64-4.22)                 1.27 (0.86-1.89)   -                                    1.81 (1.13-2.89)   1.61 (0.98-2.64)

   Most of the time                                    1.86 (1.31-2.63)   1.81 (1.23-2.66)                 1.63 (1.24-2.14)   -                                    1.63 (1.15-2.30)   1.54 (1.07-2.22)

   Some of the time                                    1.45 (1.11-1.89)   1.37 (1.02-1.83)                 1.35 (1.11-1.65)   -                                    1.56 (1.22-1.99)   1.51 (1.17-1.95)

   A little of the time                                1.19 (0.89-1.59)   1.20 (0.88-1.64)                 1.22 (0.99-1.51)   -                                    1.50 (1.16-1.94)   1.51 (1.15-1.98)

   None of the time                                    Ref           Ref                                   Ref           Ref                                       Ref           Ref

                                                                                                                                                                   

  Crack use, past 12 months                                                                                                                                        

   No                                                  Ref           Ref                                   Ref           Ref                                       Ref           Ref

   Yes                                                 2.19 (1.52-3.17)  1.66 (1.09-2.52)                  1.59 (1.15-2.20)   -                                    1.58 (1.04-2.40)   -

                                                                                                                                                                   

  Amphetamine use, past 12 months                        NS                                                  NS                                                    

   No                                                  Ref           Ref                                                                                           

   Yes                                                 1.50 (0.97-2.33)   -                                                                                        

                                                                                                                                                                   

  Binge drinking, past 30 days                                                                                                                                     

   No                                                  Ref           Ref                                   Ref           Ref                                       Ref           Ref

   Yes                                                 1.71 (1.32-2.23)   1.63 (1.21-2.20)                 1.45 (1.17-1.81)   1.55 (1.23-1.96)                     2.08 (1.60-2.72)   1.88 (1.41-2.49)

                                                                                                                                                                   

  Years since HIV diagnosis                            1.02 (1.00-1.03)   1.02 (1.00-1.04)                 NS                                                      0.98 (0.97-1.00)   -

                                                                                                                                                                   

  Number of ARV doses per day                          1.16 (1.10-1.23)   1.18 (1.10-1.25)                 1.13 (1.08-1.19)   1.16 (1.11-1.22)                     NS

                                                                                                                                                                   

  Knew most recent HIV viral load test result                                                                                                                        NS

   No                                                  1.41 (1.11-1.79)  -                                 1.86 (1.55-2.23)  1.48 (1.21-1.82)                      

   Yes                                                 Ref           Ref                                   Ref           Ref                                       

                                                                                                                                                                   

  Discussed resistance with provider, past 12 months                                                         NS                                                      NS

   No                                                  Ref           Ref                                                                                           

   Yes                                                 1.43 (1.15-1.78)   -                                                                                        
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: ART, antiretroviral therapy; OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval; Ref, reference category; NS, not significant.

*Dose nonadherence* refers to not taking a dose or set of pills/spoonfuls/injections of ARV medications.

*Schedule nonadherence* refers to not following a specific schedule for ARV medication, such as "2 times a day" or "every 8 hours."

*Instruction nonadherence* refers to not following special instructions for ARV medication, such as "take with food" or "take on an empty stomach." Dietary instruction adherence is only calculated for those participants reporting having special instructions for their ARV medications.
